Learning therapeutic lessons from metastasis suppressor proteins.
Smith. Steven Christopher SC; Theodorescu. Dan D
Key Findings
- Metastasis suppressor proteins control cancer invasion, circulation survival, and colonization.
- Potential therapies include gene transfer, re‑activating suppressed genes, or giving the protein itself.
- No such approaches are approved yet; they’re still in early research or trial stages.
Practical Outcomes
- There are no actionable protocols for biohackers or self‑experimenters. The information is mainly of interest to cancer researchers and doesn’t translate to everyday health or performance strategies.
Summary
The abstract talks about proteins that stop cancer from spreading and how scientists are trying to boost them with gene tricks or giving the proteins directly, but it doesn’t give any practical tips you can use for health, longevity, or performance.
Abstract
Metastasis suppressor proteins regulate multiple steps in the metastatic cascade, including cancer cell invasion, survival in the vascular and lymphatic circulation, and colonization of distant organ sites. Understanding the biology of metastasis suppressors provides valuable mechanistic insights that may translate to therapeutic opportunities. Several reports have explored novel strategies for restoring metastasis suppressor function, including gene transfer, induction of previously suppressed gene expression and exogenous administration of gene product. Pathways activated downstream of metastasis suppressor loss can also be targeted. Although none of these strategies are yet in routine clinical use, several are being tested preclinically and in clinical trials.
Study Information
pubmed
2009
2009-02-26T00:00:00.000Z
10.1038/nrc2594
184
125